Is aripiprazole a key to unlock anorexia nervosa?: A case series

14Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aripiprazole contributes an increase in body mass index and attenuation in anorexia nervosa (AN) symptoms, leading clinical improvements with lower side-effect profile; but it is not enough to cure comorbid depressive symptoms in AN.

Cite

CITATION STYLE

APA

Tahıllıoğlu, A., Özcan, T., Yüksel, G., Majroh, N., Köse, S., & Özbaran, B. (2020). Is aripiprazole a key to unlock anorexia nervosa?: A case series. Clinical Case Reports, 8(12), 2827–2834. https://doi.org/10.1002/ccr3.3271

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free